Effects of Low-intensity Blood-flow Restricted Exercise Compared to Standard Rehabilitation in Patients With Knee Osteoarthritis - a Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 96
- 试验地点
- 2
- 主要终点
- Knee injury and Osteoarthritis Outcome Score (KOOS) - Pain subscale
研究概览
简要总结
The purpose of this study is to investigate the effect of low-intensity BFR exercise on joint pain, muscle mass, and mechanical muscle function compared to standard rehabilitering in adults with knee-OA.
详细描述
Osteoarthritis (OA) is a common disease in Denmark with high socioeconomical costs. Representing the most widespread non-medical and non-operative treatment modality both internationally and in Denmark, knee-OA patients often are offered a combination of patient education, weight loss counseling and physical exercise. In Denmark the GLA:D (Good Life with osteoArthritis in Denmark) concept is a nationwide training paradigm which is a combination of education and supervised neuromuscular exercise (NEMEX). Physical exercise including conventional strength training has shown positive results on OA, however a large proportion of OA-patients are forced to refrain from this type of training to excessive joint- and muscle pain during and following the training sessions.
A more joint protecting type of training (BFR = Blood-Flow Restricted exercise), which are performed using low training load (<30% of maximum load) and with a reduced blood flow to the working muscles, has shown similar results to conventional heavy strength training. Based on these observations BFR exercise seems to represent an attractive training modality in patients with knee-OA.
The aim of the present study is to investigate the effect of low-intensity BFR exercise on joint pain, muscle mass, and mechanical muscle function compared to SR in adults with knee-OA. A second aim is to investigate if 12 weeks of training is more efficient compared to 8 weeks of training.
Patients diagnosed with knee-OA are eligible to participate. Inclusion takes place via the Institute of Sportsmedicine (ISMC), and the Department of Physical and Occupational Therapy at Bispebjerg Hospital. Patients will be called in for a preparatory examination by one of the attending physicians. At the consultation a standard clinical assessment will be performed and the participant will be examined for meeting the explicit inclusion or exclusion criteria of the study. If the participant after receiving all oral and written information wishes to participate in the study, an informed consent will be obtained. Randomization procedures will be performed. A randomized controlled trial design with two groups; 1) BFR, and 2) Standard rehabilitation. A total sample size of 95 participants are needed when assuming a 20 % dropout.
The intervention period will last 12 consecutive weeks with 2 weekly training sessions at several chosen physiotherapy clinics (standard rehabilitation) and at Bispebjerg Hospital (BFR). Participants in the standard rehabilitation group will be offered participation in the GLA:D programme supervised by GLA:D certified physiotherapists. The BFR group will be trained by instructors who are experienced in BFR exercise. Testing will take place before the intervention period, after 8 weeks of training and at the end of the intervention (12 weeks) except for the muscle biopsies which will take place before the intervention period and at the end (12 weeks). Patient-reported questionnaires will furthermore be assessed 6 months after the intervention period. Patients will be tested at Bispebjerg Hospital for a number of different outcome measures including joint- and muscle pain, functional level and mechanical muscle function (strength and muscle mass).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
盲法说明
Outcome assessor will be blinded to intervention allocation.
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All participants must meet the American College of Rheumatology (ACR) criteria for OA
- •Visible OA on X-ray pictures (Kellgren & Lawrence grade 2-3).
- •Unilateral pain and functional limitation for a minimum of 3 months.
- •Be able to voluntarily (i.e. unassisted) perform a 90 degrees flexion in the knee.
- •Be able to perform the machine exercise (knee extension) planned for the BFR training.
- •Danish-speaking.
- •No longer travel planned within the intervention period.
排除标准
- •Kellgren & Lawrence grade
- •Bilateral OA-symptoms.
- •Prior knee- or hip alloplasty.
- •Glucocorticosteroid injection in the knee within the last 6 months.
- •Inflammatory arthritis.
- •Known neurotic disease such as multiple sclerosis or peripheral neuropathy.
- •Prior myocardial infarct or apoplexy, or chest pain during physical activity.
- •Other health related or medical conditions which makes it impossible participate in the study.
- •Furthermore, it is an exclusion criterium in the following conditions where use of pneumatic occlusion would be considered contraindicated:
- •Peripheral vascular disease
- •Excessive varicose veins
- •Prior history of deep venous thrombosis
- •Venous insufficiency causing edema in the lower legs
- •Systolic blood pressure over 160 mmHg or under 100 mmHg
结局指标
主要结局
Knee injury and Osteoarthritis Outcome Score (KOOS) - Pain subscale
时间窗: 6 months after the training intervention period.
KOOS is a patient reported outcome instrument to assess the patient's opinion about their knee and associated problems. KOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life (QOL). Primary outcome will be an assessment of the Pain subscale as a total KOOS score has not been validated. A normalized score for the entire subscale will be calculated and reported, ranging from zero (extreme symptoms) to 100 (no symptoms).
次要结局
- Rate of Force Development (RFD)(Baseline (0 weeks), 8 weeks and 12 weeks (the end of the intervention period))
- Maximal lower limb muscle power(Baseline (0 weeks), 8 weeks and 12 weeks (the end of the intervention period))
- Maximal Voluntary Isometric Contraction (MVIC)(Baseline (0 weeks), 8 weeks and 12 weeks (the end of the intervention period))
- Stair Climb Test (SCT)(At baseline (0 weeks), 8 weeks, 12 weeks (the end of the intervention period).)
- Myocellular component (Stem cells) assessed using muscle biopsies(Baseline (0 weeks) and 12 weeks (the end of the intervention period))
- Knee injury and Osteoarthritis Outcome Score (KOOS)(At baseline (0 weeks), 8 weeks, 12 weeks (the end of the intervention period) and 6 months after the intervention period.)
- Myocellular component (Fiber area) assessed using muscle biopsies(Baseline (0 weeks) and 12 weeks (the end of the intervention period))
- Oxford Knee Score(At baseline (0 weeks), 8 weeks, 12 weeks (the end of the intervention period) and 6 months after the intervention period.)
- Pain Pressure Threshold (PPT)(Baseline (0 weeks), 8 weeks and 12 weeks (the end of the intervention period))
- 4x10m Fast-Paced Walk Test (40m-FWT)(At baseline (0 weeks), 8 weeks, 12 weeks (the end of the intervention period))
- 30-second Chair Stand Test (30-s CST)(At baseline (0 weeks), 8 weeks, 12 weeks (the end of the intervention period).)
- Myofiber Cross-Sectional Area (CSA)(Baseline (0 weeks), 8 weeks and 12 weeks (the end of the intervention period))
- Myocellular component (Myonuclei) assessed using muscle biopsies(Baseline (0 weeks) and 12 weeks (the end of the intervention period))
研究者
Brian Sorensen
Principal investigator and PhD student
Bispebjerg Hospital
